| 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ... Canadian Journal of Cardiology 33 (11), 1342-1433, 2017 | 797 | 2017 |
| Multidisciplinary approach to novel therapies in cardio-oncology research (MANTICORE 101–Breast): a randomized trial for the prevention of trastuzumab-associated cardiotoxicity E Pituskin, JR Mackey, S Koshman, D Jassal, M Pitz, MJ Haykowsky, ... Journal of Clinical Oncology 35 (8), 870-877, 2017 | 386 | 2017 |
| Pharmacist care of patients with heart failure: a systematic review of randomized trials SL Koshman, TL Charrois, SH Simpson, FA McAlister, RT Tsuyuki Archives of Internal Medicine 168 (7), 687-694, 2008 | 382 | 2008 |
| CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction M McDonald, S Virani, M Chan, A Ducharme, JA Ezekowitz, N Giannetti, ... Canadian Journal of Cardiology 37 (4), 531-546, 2021 | 235 | 2021 |
| The Canadian Cardiovascular Society heart failure companion: bridging guidelines to your practice JG Howlett, M Chan, JA Ezekowitz, K Harkness, GA Heckman, S Kouz, ... Canadian Journal of Cardiology 32 (3), 296-310, 2016 | 153 | 2016 |
| The 2014 Canadian Cardiovascular Society heart failure management guidelines focus update: anemia, biomarkers, and recent therapeutic trial implications GW Moe, JA Ezekowitz, E O'Meara, S Lepage, JG Howlett, S Fremes, ... Canadian Journal of Cardiology 31 (1), 3-16, 2015 | 152 | 2015 |
| Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: the COLLABORATE study [NCT00351676] MJ Makowsky, SL Koshman, WK Midodzi, RT Tsuyuki Medical care, 642-650, 2009 | 140 | 2009 |
| CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis E O’Meara, M McDonald, M Chan, A Ducharme, JA Ezekowitz, ... Canadian Journal of Cardiology 36 (2), 159-169, 2020 | 136 | 2020 |
| A systematic review of the evidence for pharmacist care of patients with dyslipidemia TL Charrois, M Zolezzi, SL Koshman, G Pearson, M Makowsky, T Durec, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (3 …, 2012 | 102 | 2012 |
| Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101-Breast): a randomized, placebo-controlled trial … E Pituskin, M Haykowsky, JR Mackey, RB Thompson, J Ezekowitz, ... BMC cancer 11 (1), 1-8, 2011 | 102 | 2011 |
| Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention RD Turgeon, SL Koshman, E Youngson, B Har, SB Wilton, MT James, ... JAMA Internal Medicine 180 (3), 420-428, 2020 | 97 | 2020 |
| Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease CP Walz, AR Barry, SL Koshman Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (3), 166-173, 2016 | 45 | 2016 |
| Supratherapeutic response to ezetimibe administered with cyclosporine SL Koshman, LD Lalonde, I Burton, WJ Tymchak, GJ Pearson Annals of Pharmacotherapy 39 (9), 1561-1565, 2005 | 44 | 2005 |
| Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: A secondary analysis of the MANTICORE trial AA Kirkham, E Pituskin, RB Thompson, JR Mackey, SL Koshman, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (2), 130-139, 2022 | 28 | 2022 |
| Canadian Cardiovascular Society. The 2014 Canadian Cardiovascular Society heart failure management guidelines focus update: anemia, biomarkers, and recent therapeutic trial … GW Moe, JA Ezekowitz, E O’Meara, S Lepage, JG Howlett, S Fremes, ... Can J Cardiol 31 (1), 3-16, 2015 | 28 | 2015 |
| Adverse drug reactions: The importance of maintaining pharmacovigilance AR Barry, SL Koshman, GJ Pearson Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 147 (4), 233-238, 2014 | 27 | 2014 |
| The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta‐analysis PM Schumacher, N Becker, RT Tsuyuki, N Griese‐Mammen, SL Koshman, ... ESC Heart Failure 8 (5), 3566-3576, 2021 | 23 | 2021 |
| Abstract PD5-03: Prophylactic beta blockade preserves left ventricular ejection fraction in HER2-overexpresssing breast cancer patients receiving trastuzumab: Primary results … E Pituskin, JR Mackey, S Koshman, D Jassal, M Pitz, MJ Haykowsky, ... Cancer Research 76 (4_Supplement), PD5-03-PD5-03, 2016 | 23 | 2016 |
| Independent prescribing by hospital pharmacists: patterns and practices in a Canadian province T Heck, M Gunther, L Bresee, T Mysak, C Mcmillan, S Koshman American Journal of Health-System Pharmacy 72 (24), 2166-2175, 2015 | 20 | 2015 |
| Anticoagulant therapies and outcomes in obese patients with acute venous thromboembolism S Quan, J Smith, C Wu, SL Koshman, B Nguyen, TJ Bungard Thrombosis Research 187, 56-62, 2020 | 19 | 2020 |
